ROBERTS BRIAN KENNETH
Chief Medical Officer
ROBERTS BRIAN KENNETH has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jul 7, 2026.
On the most recent filing, ROBERTS BRIAN KENNETH is listed as Chief Medical Officer at Rezolute, Inc. Inside the rolling window, ROBERTS BRIAN KENNETH reported 1 open-market purchase totaling $48K in RZLT and no open-market sales.
Companies traded
Other insiders at RZLT
Insider Buying
$48K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has ROBERTS BRIAN KENNETH made?
ROBERTS BRIAN KENNETH has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does ROBERTS BRIAN KENNETH trade?
ROBERTS BRIAN KENNETH has filed SEC Form 4 disclosures for 1 company, including RZLT.
When was ROBERTS BRIAN KENNETH's most recent SEC Form 4 filing?
ROBERTS BRIAN KENNETH's most recent SEC Form 4 filing on Tracefour is dated Jul 7, 2026.
What is ROBERTS BRIAN KENNETH's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, ROBERTS BRIAN KENNETH is listed as Chief Medical Officer.
What is ROBERTS BRIAN KENNETH's total buy and sell value in the current window?
Inside the rolling retention window, ROBERTS BRIAN KENNETH bought $48K and sold $0 based on SEC Form 4 filings.
What was ROBERTS BRIAN KENNETH's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 28,000 RZLT shares on 2025-12-16, worth $48K, per SEC Form 4 filings.